Catheter-related bloodstream infections (CBIs) rank among the most frequent
and potentially lethal nosocomial infections. Intravascular devices become
contaminated on the outer surface during nonaseptic insertion or maintenan
ce of the catheter exit site or endoluminally during hub manipulation. CBI
is heralded by spiking fever, malaise and rigors and should be promptly dia
gnosed to prevent endocarditis and septic metastasis. In about two-thirds o
f the cases the offending organisms are coagulase-negative staphylococci; S
taphylococcus aureus, gram-negative bacilli, and Candida sp. are responsibl
e for one-third of these infections and carry a worse prognosis. Diagnosis
of CBI relies on proper bacteriologic techniques, some of which can be perf
ormed in situ avoiding withdrawal of the device. Prevention strategies shou
ld aim at avoiding extra- and endoluminal contamination and should be based
on three main pillars: maximal aseptic barriers at insertion, appropriate
site maintenance, and junctional (hub) care and protection. Treatment inclu
des catheter withdrawal and appropriate antibiotic coverage. For long term
cuffed catheters, local treatment with intraluminal administration of antib
iotics is effective and can save a significant number of catheters, particu
larly those colonized by coagulase-negative staphylococci.